SCHEMBL28026704

SCHEMBL28026704

N#CC=C1CCN(CC(=O)O)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
OPRK1 P41145 2/20 0.34
SLC6A9 P48067 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
MPI P34949 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DRD3 P35462 1/20 0.33
CYP1A2 P05177 1/20 0.30
GRM5 P41594 1/20 0.30
ACE P12821 1/20 0.30
S1PR1 P21453 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28153950 0.80 DRD3 (0.37) OPRK1DRD3
SCHEMBL30990313 0.73 DRD3 (0.43) HSD17B10OPRK1KDM4EALDH1A1MAPT
Tetraxetan SCHEMBL6260240 0.71 HSD17B10 (0.61) HSD17B10SLC6A9KDM4EALDH1A1MAPT
Tetraxetan SCHEMBL1880329 0.71 HSD17B10 (0.61) HSD17B10SLC6A9KDM4EALDH1A1MAPT
SCHEMBL2422131 0.70 HSD17B10 (0.50) HSD17B10SLC6A9KDM4EALDH1A1MAPT
SCHEMBL20994916 0.69 USP30 (0.33) OPRK1CYP1A2GRM5
SCHEMBL27166201 0.69 ALDH1A1 (0.45) OPRK1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL11427988 0.69 HSD17B10 (0.48) HSD17B10SLC6A9KDM4EALDH1A1MAPT
SCHEMBL9693848 0.69 HSD17B10 (0.48) HSD17B10SLC6A9KDM4EALDH1A1MAPT
Tetraxetan SCHEMBL18018 0.68 HSD17B10 (0.64) HSD17B10SLC6A9KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105189498-A Geminally substituted cyanoethylpyrazolopyridinones as JANUS kinase inhibitors MERCK SHARP & DOHME 2015-12-23 CN disclosed